1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S.; Zhang, H.; Nissan, M.; Kundra, R.; Su, J.; LaFave, L.; Gala, K.; Vanderbilt, C.; Arcila, M.; Ladanyi, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Germline mutation prevalence in young adults with cancer
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Padunan, A.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Belanfanti, K.; Tejada, P. R.; Birsoy, O.; Mandelker, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The Virtual Molecular Tumor Board of the Variant Interpretation for Cancer Consortium: A systematic gateway connecting cancer genome interpretation and progress in genomic knowledgebases in cancer
    Meeting Abstract

    Pitel, B. A.; Rao, S.; Del Vecchio Fitz, C.; Madhavan, S.; Dientsmann, R.; Horak, P.; King, I.; Mockus, S. M.; Raca, G.; Rieke, D. T.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genetic algorithms to identify homologous recombination deficiency (HRD) in pancreas adenocarcinoma
    Meeting Abstract

    Park, W.; Chen, J.; Chou, J. F.; Iacobuzio-Donague, C.; Riaz, N.; O'Reilly, E. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Acquired stemness by luminal cells
    Meeting Abstract

    Karthaus, W.; Hofree, M.; Choi, D.; Linton, E. L.; Turkekul, M.; Bejnood, A.; Carver, B.; Gopalan, A.; Laudone, V.; Biton, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Loss of function of the BRCA1-PALB2-BRCA2 axis accelerates p53-associated tumorigenesis
    Meeting Abstract

    Huo, Y.; Mahdi, A.; Selenica, P.; Reis-Filho, J. S. S.; Weigelt, B.; Xia, B.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A standard operating procedure for the interpretation of oncogenicity/pathogenicity of somatic mutations
    Meeting Abstract

    Horak, P.; Griffith, M.; Danos, A.; Pitel, B. A.; Madhavan, S.; Liu, X.; Lee, J.; Raca, G.; Li, S.; Wagner, A. H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas
    Meeting Abstract

    Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save